← Eichor
Condition: Skin Infection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Skin Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Personalised Immunotherapy Platform
Phase N/A · 3 location(s) · Melanoma Institute Australia · NCT06536257Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts
Phase 2 · 1 location(s) · Zagazig University · NCT05291845Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL
Phase 3 · 28 location(s) · Jena University Hospital · NCT06134492AnovaOS Network Powered Patient Registry
Phase N/A · 1 location(s) · Anova Enterprises, Inc · NCT05013944The MARVIN Chatbots to Provide Information for Different Health Conditions
NA · 2 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT05789901Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammato
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06599411Collection and Distribution of Biospecimens for Novel Research Uses
Phase N/A · 2 location(s) · iSpecimen Inc · NCT03848962Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativ
Phase 1 · 21 location(s) · Incyte Corporation · NCT07049575A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
Phase 4 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07220967Determinants of Chronic Inflammatory Skin Disease Trajectories
Phase N/A · 1 location(s) · University Hospital Schleswig-Holstein · NCT05928169Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial
Phase 4 · 1 location(s) · Frieder Schaumburg · NCT05899140Lupus Landmark Study: A Prospective Registry and Biorepository
Phase N/A · 25 location(s) · Lupus Research Alliance · NCT05934149Radiotherapy for Refractory Hidradenitis Suppurativa
NA · 2 location(s) · Thomas Jefferson University · NCT07414550The Application of Infrared Thermography in the Prediction of Skin Healing in Surgery
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07524062Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Effect of MTX Discontinuation on Shingrix Response in RA
NA · 1 location(s) · Konkuk University Medical Center · NCT06574594Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Phase 1/Phase 2 · 1 location(s) · Thomas Advanced Medical LLC · NCT04684602Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
Phase 2 · 1 location(s) · KTH Biopharma · NCT07698886Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced Paronychia
Phase 3 · 1 location(s) · Queen Mary Hospital, Hong Kong · NCT06643416A Pilot Study to Evaluate the Therapeutic Efficacy of Intra-Lesional Immunotherapy in Patients Aged 10-60 Years With Rec
NA · 1 location(s) · Abeer Mohamed Abdelaziz Elkholy · NCT07312604Multicenter Real-World Study of Hyperthermia in Warts of Special Population
NA · 1 location(s) · First Hospital of China Medical University · NCT06827938Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis
Phase 2 · 1 location(s) · Hayder Adnan Fawzi · NCT06798415Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
Phase N/A · 2 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT04198740Safety of Administering Isoniazid to SLE Patients to Prevent TB
Phase 2/Phase 3 · 1 location(s) · Universitas Padjadjaran · NCT06618573UNC Pleural Fluid Registry
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05620329An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
Phase 3 · 4 location(s) · Novartis Pharmaceuticals · NCT07665437Telacebec (T) Treatment in Adults With Buruli Ulcer (BU). (TREAT BU)
Phase 2 · 2 location(s) · Barwon Health · NCT06481163Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients
Phase 3 · 4 location(s) · Institut Pasteur · NCT05821478OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis Patients
Phase N/A · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT06514560Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children
NA · 1 location(s) · Alexandria University · NCT07184203
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.